Belgium· BE-AMP-SAM499537-00
Transisoft 8.5 g
A macrogol product containing macrogol, registered in Belgium by Laboratoires Mayoly Spindler. The same ATC class is registered in 12 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Macrogol is registered in 12 of 19 countries.
Countries holding a registration under ATC A06AD15 (macrogol), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 7 of them publish a price we can compare per daily dose
Macrogol · ATC A06AD15
12 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Switzerlandprice
Price per daily dose
What a daily dose of macrogol costs, country by country.
Normalised to the WHO defined daily dose (10 g), the median price runs from $0.083 in Finland to $0.66 in Switzerland — a ×7.9 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Macrogol · price per daily dose (10 g)
USD · FX 28 Sept 2026
- CH Switzerland$0.66
- FI Finland$0.083
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Macrogol
- Manufacturer
- Laboratoires Mayoly Spindler
- Country
- Belgium (BE)
- ATC code
- A06AD15
- ATC class
- Macrogol
- Defined daily dose
- 10 g, O
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 1
- be_apb3537081
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
449 interactions on record for macrogol.
Graded by severity as the source publishes them — 37 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Macrogol · interactions on record
449 records
- 37 severe
- 411 moderate
- 1 minor
Most severe, free to view
- CisaprideA03FA02severe
- DolasetronA04AA04severe
- QuinidineC01BA01severe
- ProcainamideC01BA02severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Macrogol in 3 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/dde19d10-9e1e-4a79-bd79-4482d7254d65 GET /v1/drugs/dde19d10-9e1e-4a79-bd79-4482d7254d65?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Powder for oral solution in sachet",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Transisoft 8.5 g",
"name_fr": "Transisoft 8.5 g",
"name_nl": "Transisoft 8.5 g",
"amp_code": "SAM499537-00",
"strengths": [
"8.5000"
],
"pack_count": 2,
"substances": [
"Macrogol"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Macrogol",
"authorisation_numbers": [
"BE499537"
]
}See everything about macrogol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.